JP2013543489A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543489A5 JP2013543489A5 JP2013530130A JP2013530130A JP2013543489A5 JP 2013543489 A5 JP2013543489 A5 JP 2013543489A5 JP 2013530130 A JP2013530130 A JP 2013530130A JP 2013530130 A JP2013530130 A JP 2013530130A JP 2013543489 A5 JP2013543489 A5 JP 2013543489A5
- Authority
- JP
- Japan
- Prior art keywords
- block copolymer
- composition
- micelle
- drug
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001400 block copolymer Polymers 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- 239000000693 micelle Substances 0.000 claims description 10
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 9
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 8
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 7
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 150000007970 thio esters Chemical class 0.000 claims description 2
- 150000007944 thiolates Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 12
- 229940079593 drug Drugs 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 230000007704 transition Effects 0.000 claims 6
- 230000008685 targeting Effects 0.000 claims 4
- 238000003384 imaging method Methods 0.000 claims 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- QZPQTZZNNJUOLS-UHFFFAOYSA-N beta-lapachone Chemical compound C12=CC=CC=C2C(=O)C(=O)C2=C1OC(C)(C)CC2 QZPQTZZNNJUOLS-UHFFFAOYSA-N 0.000 claims 2
- 210000001163 endosome Anatomy 0.000 claims 2
- -1 n- butyl Chemical group 0.000 claims 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 1
- 230000002491 angiogenic effect Effects 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 238000010494 dissociation reaction Methods 0.000 claims 1
- 230000005593 dissociations Effects 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 102000006495 integrins Human genes 0.000 claims 1
- 108010044426 integrins Proteins 0.000 claims 1
- 230000002132 lysosomal effect Effects 0.000 claims 1
- 210000003712 lysosome Anatomy 0.000 claims 1
- 230000001868 lysosomic effect Effects 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- 229920000193 polymethacrylate Polymers 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 2
- GRAVJJAQKJDGPM-UHFFFAOYSA-N 3-[2-[7-[3-(2-carboxyethyl)-1,1-dimethylbenzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]propanoic acid;bromide Chemical compound [Br-].OC(=O)CCN1C2=CC=C3C=CC=CC3=C2C(C)(C)\C1=C/C=C/C=C/C=C/C1=[N+](CCC(O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C GRAVJJAQKJDGPM-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38542210P | 2010-09-22 | 2010-09-22 | |
| US61/385,422 | 2010-09-22 | ||
| US201161470441P | 2011-03-31 | 2011-03-31 | |
| US61/470,441 | 2011-03-31 | ||
| US201161471054P | 2011-04-01 | 2011-04-01 | |
| US61/471,054 | 2011-04-01 | ||
| PCT/US2011/001418 WO2012039741A1 (en) | 2010-09-22 | 2011-08-11 | Novel block copolymer and micelle compositions and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016175152A Division JP6471129B2 (ja) | 2010-09-22 | 2016-09-08 | 新規ブロックコポリマーおよびミセル組成物ならびにその使用法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013543489A JP2013543489A (ja) | 2013-12-05 |
| JP2013543489A5 true JP2013543489A5 (cg-RX-API-DMAC10.html) | 2016-02-25 |
Family
ID=45874087
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013530130A Pending JP2013543489A (ja) | 2010-09-22 | 2011-08-11 | 新規ブロックコポリマーおよびミセル組成物ならびにその使用法 |
| JP2016175152A Active JP6471129B2 (ja) | 2010-09-22 | 2016-09-08 | 新規ブロックコポリマーおよびミセル組成物ならびにその使用法 |
| JP2019007460A Active JP6812471B2 (ja) | 2010-09-22 | 2019-01-21 | 新規ブロックコポリマーおよびミセル組成物ならびにその使用法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016175152A Active JP6471129B2 (ja) | 2010-09-22 | 2016-09-08 | 新規ブロックコポリマーおよびミセル組成物ならびにその使用法 |
| JP2019007460A Active JP6812471B2 (ja) | 2010-09-22 | 2019-01-21 | 新規ブロックコポリマーおよびミセル組成物ならびにその使用法 |
Country Status (7)
| Country | Link |
|---|---|
| US (10) | US20140023590A1 (cg-RX-API-DMAC10.html) |
| EP (3) | EP3170846A1 (cg-RX-API-DMAC10.html) |
| JP (3) | JP2013543489A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2011306076B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2811692C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2626437T3 (cg-RX-API-DMAC10.html) |
| WO (2) | WO2012039741A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201807363T4 (tr) | 2010-09-22 | 2018-06-21 | Univ Texas | Hedefleyici nqo1 i içeren kanser tedavi yöntemleri. |
| WO2012039741A1 (en) | 2010-09-22 | 2012-03-29 | The Board Of Regents Of The University Of Texas System | Novel block copolymer and micelle compositions and methods of use thereof |
| US9511152B2 (en) * | 2012-04-05 | 2016-12-06 | The Board Of Regents Of The University Of Texas System | Multicolored pH-activatable fluorescence nanoplatform |
| CN103215577B (zh) * | 2012-05-07 | 2015-04-01 | 中国科学院苏州纳米技术与纳米仿生研究所 | 在金属表面制备具有pH响应性的高分子膜的方法 |
| CN102942918A (zh) * | 2012-11-08 | 2013-02-27 | 中国科学院化学研究所 | 一种聚甜菜碱荧光标记剂及其制备方法 |
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| ES3054697T3 (en) * | 2013-09-17 | 2026-02-05 | Blaze Bioscience Inc | Chlorotoxin conjugates and methods of use thereof |
| US11559580B1 (en) | 2013-09-17 | 2023-01-24 | Blaze Bioscience, Inc. | Tissue-homing peptide conjugates and methods of use thereof |
| CN106573076A (zh) * | 2014-06-06 | 2017-04-19 | 德克萨斯大学系统董事会 | pH响应聚合物库及其纳米探针 |
| WO2016004369A1 (en) | 2014-07-02 | 2016-01-07 | The Research Foundation For The State University Of New York | Surfactant-stripped micelle compositions with high cargo to surfactant ratio |
| WO2016138461A1 (en) | 2015-02-26 | 2016-09-01 | Sony Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| CN109069440A (zh) * | 2016-03-02 | 2018-12-21 | 得克萨斯州大学系统董事会 | 用于免疫治疗的激活sting的纳米疫苗 |
| BR112018070164B1 (pt) | 2016-04-01 | 2022-09-27 | Sony Corporation Of America | Corantes diméricos ou poliméricos ultrabrilhantes |
| CN109153860B (zh) | 2016-04-06 | 2021-04-23 | 索尼公司 | 具有间隔连接体基团的超高亮二聚体或聚合物染料 |
| US12048732B2 (en) | 2016-04-15 | 2024-07-30 | Blaze Bioscience, Inc. | Methods of treating breast cancer |
| BR112018073199A2 (pt) | 2016-05-11 | 2019-04-16 | Sony Corporation | corantes diméricos ou poliméricos ultrabrilhantes |
| WO2018022925A1 (en) | 2016-07-29 | 2018-02-01 | Sony Corporation | Ultra bright dimeric or polymeric dyes and methods for preparation of the same |
| CN106432647B (zh) * | 2016-09-26 | 2018-10-30 | 华南理工大学 | 基于叔氨基的pH响应嵌段聚合物及其混合胶束与应用 |
| US10188606B2 (en) * | 2016-10-07 | 2019-01-29 | Mayo Foundation For Medical Education And Research | Expansile crosslinked polymersome for pH-sensitive delivery of anticancer drugs |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| US12290571B2 (en) | 2017-10-05 | 2025-05-06 | Sony Group Corporation | Programmable dendritic drugs |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| CN111465608A (zh) * | 2017-12-13 | 2020-07-28 | 索尼公司 | 包含生物学活性化合物的离子型聚合物 |
| CN111712468A (zh) | 2017-12-22 | 2020-09-25 | 北卡罗莱纳州立大学 | 聚合物荧光团、包含其的组合物及制备和使用其的方法 |
| US12076407B2 (en) | 2018-01-12 | 2024-09-03 | Sony Group Corporation | Polymers with rigid spacing groups comprising biologically active compounds |
| WO2019140128A1 (en) | 2018-01-12 | 2019-07-18 | Sony Corporation | Phosphoalkyl polymers comprising biologically active compounds |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| EP3769085B1 (en) | 2018-03-19 | 2022-08-24 | Sony Group Corporation | Use of divalent metals for enhancement of fluorescent signals |
| KR102864292B1 (ko) | 2018-03-21 | 2025-09-26 | 소니그룹주식회사 | 링커 군을 갖는 중합체성 텐덤 염료 |
| WO2019204799A1 (en) | 2018-04-20 | 2019-10-24 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| US12578342B2 (en) | 2018-07-13 | 2026-03-17 | Sony Group Corporation | Polymeric dyes having a backbone comprising organophosphate units |
| JP7538117B2 (ja) * | 2018-09-15 | 2024-08-21 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 腫瘍アシドーシス画像化のためのデュアルモダリティｕｐｓナノプローブ |
| CN112823000A (zh) * | 2018-10-12 | 2021-05-18 | 联邦高等教育系统匹兹堡大学 | 用于试剂递送的小聚合物载体 |
| CN109738402B (zh) * | 2018-12-27 | 2022-05-27 | 南方医科大学 | 一种表面活性剂临界胶束浓度的荧光探针滴定法 |
| CN110078948B (zh) * | 2019-04-29 | 2021-09-24 | 西北师范大学 | 一种具有pH响应性陶罐状聚合物微球及其制备方法 |
| BR112021023940A2 (pt) * | 2019-05-28 | 2022-02-15 | Univ Texas | Composições responsivas ao ph e usos das mesmas |
| US20220226239A1 (en) * | 2019-06-04 | 2022-07-21 | Aravasc Inc. | Polymeric micelle complexes, formulations, and uses thereof |
| EP3861074A2 (en) | 2019-09-26 | 2021-08-11 | Sony Group Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| CA3159915A1 (en) * | 2019-11-04 | 2021-05-14 | Onconano Medicine, Inc. | Ph responsive block copolymer compositions, micelles, and methods of use |
| AU2021256326A1 (en) * | 2020-04-15 | 2022-10-20 | Queensland University Of Technology | Fluorescent macromolecule and uses thereof |
| WO2021217111A1 (en) | 2020-04-24 | 2021-10-28 | The Board Of Regents Of The University Of Texas System | Ph responsive block copolymer compositions and micelles that inhibit mct 1 and related proteins |
| EP4240781A4 (en) * | 2020-11-03 | 2026-02-18 | Onconano Medicine Inc | pH-sensitive therapeutic compositions |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| US20250009656A1 (en) * | 2021-11-15 | 2025-01-09 | The Board Of Regents Of The University Of Texas System | Ultra ph-sensitive micelles encapsulating cytokines for treatment of cancer |
| CN115785346B (zh) * | 2022-01-20 | 2025-07-18 | 北京大学 | 含非pH敏感型单体的pH敏感聚合物的合成及应用 |
| KR20250110251A (ko) * | 2022-11-06 | 2025-07-18 | 온코나노 메디신, 인크. | 이중특이적 항체 및 시토카인의 양성자화된 pH 반응성 중합체 캡슐화 |
| CN116333190B (zh) * | 2023-03-06 | 2024-05-24 | 郑州大学 | 一种多重响应的前药聚合物、制备方法和应用 |
| CN116730969B (zh) * | 2023-06-26 | 2024-04-19 | 中国药科大学 | 一种β-拉帕醌-氨基酸缀合物及其制备方法和应用 |
| AU2024397320A1 (en) * | 2023-12-15 | 2026-07-09 | The Board Of Regents Of The University Of Texas System | Stimuli-responsive sting-activating polymer compositions and methods of use |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB475131A (en) | 1935-05-16 | 1937-11-15 | Du Pont | Esters of acids of the acrylic series and their applications |
| GB1174148A (en) | 1967-08-11 | 1969-12-10 | Nii Monomerov Dlya Sint Kauchu | Method of producing Acrylic and Methacrylic Esters |
| CS225516B1 (cs) | 1982-07-29 | 1984-02-13 | Vacik Jiri | Způsob výroby béziekých esterů kyseliny methakrylové |
| US6660793B1 (en) | 2000-06-15 | 2003-12-09 | E. I. Du Pont De Nemours And Company | Aqueous coating compositions having improved transparency |
| EP1325046B1 (en) * | 2000-10-06 | 2007-06-27 | Biocompatibles UK Limited | Zwitterionic polymers |
| US6939564B2 (en) | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
| EP1340492A1 (en) | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
| AU2003214387A1 (en) | 2002-03-07 | 2003-09-16 | Biocompatibles Uk Limited | Drug carriers comprising amphiphilic block copolymers |
| WO2005072752A1 (ja) * | 2004-01-30 | 2005-08-11 | Taisho Pharmaceutical Co., Ltd. | 高リン血症の予防又は治療剤 |
| WO2006020719A2 (en) * | 2004-08-11 | 2006-02-23 | Arqule, Inc. | Aminoacid conjugates of beta - lapachone for tumor targeting |
| US7514400B2 (en) | 2004-10-06 | 2009-04-07 | The Penn State Research Foundation | Synthetic mimics of mammalian cell surface receptors: method and compositions |
| WO2006078914A1 (en) * | 2005-01-21 | 2006-07-27 | Washington University In St. Louis | Compounds having rd targeting motifs |
| US20090317802A1 (en) | 2005-12-09 | 2009-12-24 | Bhatia Sangeeta N | Compositions and Methods to Monitor RNA Delivery to Cells |
| US20080081075A1 (en) | 2006-10-02 | 2008-04-03 | National Tsing Hua University | Multifunctional mixed micelle of graft and block copolymers and preparation thereof |
| US20080248097A1 (en) * | 2007-02-26 | 2008-10-09 | Kwon Glen S | Polymeric micelles for combination drug delivery |
| WO2009061473A2 (en) | 2007-11-07 | 2009-05-14 | Mallinckrodt Inc. | Photonic shell-core cross linked and functionalized nanostructures for biological applications |
| FR2924432B1 (fr) | 2007-11-30 | 2010-10-22 | Cray Valley Sa | Dispersion aqueuse de polymere structuree en coeur/ecorce, son procede de preparation et son application dans les revetements |
| CA2724014C (en) * | 2008-05-13 | 2016-09-13 | University Of Washington | Micellic assemblies |
| US9732142B2 (en) * | 2008-05-15 | 2017-08-15 | Biocompatibles Uk Limited | Intracellular antibody delivery |
| WO2009149308A2 (en) | 2008-06-04 | 2009-12-10 | Seventh Sense Biosystems, Inc. | Compositions and methods for rapid one-step diagnosis |
| CA2745926A1 (en) * | 2008-12-08 | 2010-07-08 | Phaserx, Inc. | Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization |
| WO2010116063A1 (fr) | 2009-04-09 | 2010-10-14 | L'oreal | Copolymère éthylénique à motifs peg, cationique et anionique, composition cosmétique le comprenant et procédé de traitement |
| US20100303731A1 (en) | 2009-05-29 | 2010-12-02 | Searete Llc | Systems, devices, methods, and compositions including selectively accessible ferromagnetic structures |
| WO2011097384A2 (en) | 2010-02-04 | 2011-08-11 | Board Of Regents, The University Of Texas System | Tumor targeted delivery of immunomodulators by nanoplymers |
| WO2012040513A1 (en) | 2010-09-22 | 2012-03-29 | The Board Of Regents Of The University Of Texas System | Compositions and methods for the delivery of beta lapachone |
| WO2012039741A1 (en) | 2010-09-22 | 2012-03-29 | The Board Of Regents Of The University Of Texas System | Novel block copolymer and micelle compositions and methods of use thereof |
| US9511152B2 (en) | 2012-04-05 | 2016-12-06 | The Board Of Regents Of The University Of Texas System | Multicolored pH-activatable fluorescence nanoplatform |
| KR101405333B1 (ko) | 2013-09-12 | 2014-06-11 | 유비머트리얼즈주식회사 | 연마 입자, 연마 슬러리 및 이를 이용한 반도체 소자의 제조 방법 |
-
2011
- 2011-08-11 WO PCT/US2011/001418 patent/WO2012039741A1/en not_active Ceased
- 2011-08-11 WO PCT/US2011/047497 patent/WO2012039855A1/en not_active Ceased
- 2011-08-11 CA CA2811692A patent/CA2811692C/en active Active
- 2011-08-11 JP JP2013530130A patent/JP2013543489A/ja active Pending
- 2011-08-11 EP EP16204435.8A patent/EP3170846A1/en not_active Withdrawn
- 2011-08-11 ES ES11827074.3T patent/ES2626437T3/es active Active
- 2011-08-11 US US13/825,518 patent/US20140023590A1/en not_active Abandoned
- 2011-08-11 US US13/825,524 patent/US9631041B2/en not_active Expired - Fee Related
- 2011-08-11 EP EP17205562.6A patent/EP3345944B1/en active Active
- 2011-08-11 AU AU2011306076A patent/AU2011306076B2/en not_active Expired - Fee Related
- 2011-08-11 EP EP11827074.3A patent/EP2619238B1/en active Active
-
2016
- 2016-03-17 US US15/072,522 patent/US9751970B2/en active Active
- 2016-09-08 JP JP2016175152A patent/JP6471129B2/ja active Active
-
2017
- 2017-07-27 US US15/662,184 patent/US10017598B2/en active Active
-
2018
- 2018-06-13 US US16/006,885 patent/US11098150B2/en active Active
-
2019
- 2019-01-21 JP JP2019007460A patent/JP6812471B2/ja active Active
-
2020
- 2020-03-10 US US16/814,845 patent/US20200330383A1/en active Granted
- 2020-03-10 US US16/814,898 patent/US20200333350A1/en not_active Abandoned
- 2020-03-10 US US16/814,803 patent/US20200325265A1/en not_active Abandoned
-
2021
- 2021-03-10 US US17/198,006 patent/US12528903B2/en active Active
-
2022
- 2022-07-01 US US17/810,591 patent/US12091486B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xiang et al. | Multipotent Poly (Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery | |
| Miao et al. | Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel | |
| Li et al. | Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy | |
| Chen et al. | Receptor and microenvironment dual-recognizable nanogel for targeted chemotherapy of highly metastatic malignancy | |
| Li et al. | Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA | |
| Ge et al. | Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors | |
| Ganas et al. | Biodegradable capsules as non-viral vectors for in vitro delivery of PEI/siRNA polyplexes for efficient gene silencing | |
| Zhao et al. | Reduction-responsive core–shell–corona micelles based on triblock copolymers: novel synthetic strategy, characterization, and application as a tumor microenvironment-responsive drug delivery system | |
| Xiong et al. | Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy | |
| Chen et al. | Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors | |
| Wang et al. | Tuning the architecture of polymeric conjugate to mediate intracellular delivery of pleiotropic curcumin | |
| Li et al. | Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel | |
| Luan et al. | Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice | |
| Louage et al. | Degradable ketal-based block copolymer nanoparticles for anticancer drug delivery: a systematic evaluation | |
| Huang et al. | Bridging the gap between macroscale drug delivery systems and nanomedicines: a nanoparticle-assembled thermosensitive hydrogel for peritumoral chemotherapy | |
| Jain et al. | Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries | |
| Wang et al. | pH, redox and photothermal tri-responsive DNA/polyethylenimine conjugated gold nanorods as nanocarriers for specific intracellular co-release of doxorubicin and chemosensitizer pyronaridine to combat multidrug resistant cancer | |
| Cosco et al. | Physicochemical features and transfection properties of chitosan/poloxamer 188/poly (D, L-lactide-co-glycolide) nanoplexes | |
| EP2810661A3 (en) | Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids | |
| Rahme et al. | Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery | |
| WO2012039855A1 (en) | Ph-sensitive compositions for delivery of beta lapachone and methods of use | |
| Wu et al. | Methotrexate-conjugated AgInS2/ZnS quantum dots for optical imaging and drug delivery | |
| Liu et al. | Drug Self‐Delivery Systems: Molecule Design, Construction Strategy, and Biological Application | |
| US9822202B2 (en) | Polymer/copper combination for targeted cancer therapy | |
| Wu et al. | Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia |